Document is current
Any future updates will be listed below
-
Authors
Mangiante, Lise https://orcid.org/0000-0001-8309-0950
Alcala, Nicolas https://orcid.org/0000-0002-5961-5064
Sexton-Oates, Alexandra
Di Genova, Alex
Gonzalez-Perez, Abel https://orcid.org/0000-0002-8582-4660
Khandekar, Azhar
Bergstrom, Erik N.
Kim, Jaehee https://orcid.org/0000-0002-5210-2004
Liu, Xiran
Blazquez-Encinas, Ricardo
Giacobi, Colin
Le Stang, Nolwenn
Boyault, Sandrine https://orcid.org/0000-0002-2297-6894
Cuenin, Cyrille
Tabone-Eglinger, Severine https://orcid.org/0000-0003-4247-1321
Damiola, Francesca https://orcid.org/0000-0002-0238-1252
Voegele, Catherine
Ardin, Maude
Michallet, Marie-Cecile
Soudade, Lorraine
Delhomme, Tiffany M. https://orcid.org/0000-0003-0265-4246
Poret, Arnaud
Brevet, Marie
Copin, Marie-Christine
Giusiano-Courcambeck, Sophie
Damotte, Diane
Girard, Cecile
Hofman, Veronique
Hofman, Paul
Mouroux, Jérôme
Cohen, Charlotte
Lacomme, Stephanie
Mazieres, Julien
de Montpreville, Vincent Thomas
Perrin, Corinne
Planchard, Gaetane
Rousseau, Nathalie
Rouquette, Isabelle
Sagan, Christine
Scherpereel, Arnaud
Thivolet, Francoise
Vignaud, Jean-Michel
Jean, Didier
Ilg, Anabelle Gilg Soit
Olaso, Robert https://orcid.org/0000-0001-7631-9657
Meyer, Vincent
Boland-Auge, Anne https://orcid.org/0000-0001-8789-5676
Deleuze, Jean-Francois https://orcid.org/0000-0002-5358-4463
Altmuller, Janine
Nuernberg, Peter
Ibáñez-Costa, Alejandro https://orcid.org/0000-0003-4649-0095
Castaño, Justo P. https://orcid.org/0000-0002-3145-7287
Lantuejoul, Sylvie
Ghantous, Akram
Maussion, Charles https://orcid.org/0000-0003-2266-5276
Courtiol, Pierre
Hernandez-Vargas, Hector https://orcid.org/0000-0001-6045-2103
Caux, Christophe
Girard, Nicolas
Lopez-Bigas, Nuria https://orcid.org/0000-0003-4925-8988
Alexandrov, Ludmil B.
Galateau-Salle, Françoise https://orcid.org/0000-0002-2814-1644
Foll, Matthieu https://orcid.org/0000-0001-9006-8436
Fernandez-Cuesta, Lynnette https://orcid.org/0000-0002-0724-6703
- License Information
-
More Information
Article History
Received: 25 December 2021
Accepted: 26 January 2023
First Online: 16 March 2023
Competing interests
: Where authors are identified as personnel of the IARC/WHO, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the IARC/WHO. Where authors are identified as personnel of the Centre de Recherche en Cancérologie de Lyon, the authors declare no competing interests. A.S. participated in expert boards and clinical trials with AstraZeneca, Bristol-Myers Squibb, MSD and Roche. N.G. declares consultancy for and research support from Bristol-Myers Squibb, AstraZeneca, Roche and MSD. S Lantuejoul declares research support from AstraZeneca, Sanofi, Bristol-Myers Squibb, Janssen and Eli Lilly and has participated in expert boards for MSD and Bristol-Myers Squibb. D.D. declares research support from AstraZeneca. J. Mazieres declares consultancy for and research support from Roche, AstraZeneca, Bristol-Myers Squibb, MSD and Pierre Fabre. M.B. declares consultancy for and research support from AstraZeneca, Bristol-Myers Squibb and Amgen. I.R. participated in expert boards for AstraZeneca, MSD and Bristol-Myers Squibb. L.B.A. is a compensated consultant and has equity interest in io9. His spouse is an employee of Biotheranostics. L.B.A. is also an inventor on a US patent (10,776,718) relating to source identification by non-negative matrix factorization. E.N.B. and L.B.A. declare US provisional patent applications with the serial numbers 63/289,601 and 63/269,033. L.B.A. declares US provisional patent applications with the serial numbers 63/366,392, 63/367,846 and 63/412,835. C.M. is employed by and has equity interest in Owkin. C.M., P.C. and F.G.-S. are inventors on the US patent 17185924 ‘Systems and methods for mesothelioma feature detection and enhanced prognosis or response to treatment’. All other authors declare no competing interests.
